Shares of Trupanion, Inc. (NASDAQ:TRUP – Get Rating) traded down 8% during trading on Thursday . The stock traded as low as $59.28 and last traded at $59.80. 3,797 shares traded hands during mid-day trading, a decline of 99% from the average session volume of 415,623 shares. The stock had previously closed at $64.97.

Analysts Set New Price Targets

Several equities analysts have recently commented on the stock. Northland Securities decreased their price objective on shares of Trupanion from $80.00 to $70.00 in a report on Thursday, August 4th. Piper Sandler downgraded shares of Trupanion from an "overweight" rating to a "neutral" rating and cut their target price for the stock from $80.00 to $69.00 in a research note on Thursday, August 4th. Evercore ISI cut their target price on shares of Trupanion to $85.00 in a research note on Tuesday, August 9th. Canaccord Genuity Group cut their target price on shares of Trupanion from $100.00 to $90.00 in a research note on Friday, August 5th. Finally, Jefferies Financial Group began coverage on shares of Trupanion in a research note on Wednesday. They set a "buy" rating and a $77.00 target price on the stock. One investment analyst has rated the stock with a sell rating, one has given a hold rating and two have assigned a buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $88.71.

Trupanion Stock Performance

The stock's 50-day simple moving average is $68.33 and its 200 day simple moving average is $70.19. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.78 and a current ratio of 1.78. The company has a market capitalization of $2.42 billion, a PE ratio of -66.62 and a beta of 1.95.

Insider Buying and Selling at Trupanion

In related news, Director Michael Doak sold 700 shares of the stock in a transaction on Tuesday, July 5th. The shares were sold at an average price of $60.00, for a total value of $42,000.00. Following the transaction, the director now directly owns 1,007 shares of the company's stock, valued at approximately $60,420. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In related news, Director Michael Doak sold 700 shares of the stock in a transaction on Tuesday, July 5th. The shares were sold at an average price of $60.00, for a total value of $42,000.00. Following the transaction, the director now directly owns 1,007 shares of the company's stock, valued at approximately $60,420. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Darryl Rawlings sold 4,000 shares of the stock in a transaction on Wednesday, September 14th. The shares were sold at an average price of $65.57, for a total transaction of $262,280.00. Following the completion of the transaction, the chief executive officer now directly owns 857,109 shares in the company, valued at $56,200,637.13. The disclosure for this sale can be found here. In the last three months, insiders have sold 28,207 shares of company stock valued at $1,934,952. Insiders own 5.86% of the company's stock.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the stock. Greenhaven Road Investment Management L.P. acquired a new stake in Trupanion during the 2nd quarter worth $32,000. Prospera Financial Services Inc acquired a new stake in Trupanion during the 1st quarter worth $49,000. Tcwp LLC acquired a new stake in Trupanion during the 1st quarter worth $54,000. Harbor Investment Advisory LLC boosted its stake in Trupanion by 31.9% during the 2nd quarter. Harbor Investment Advisory LLC now owns 942 shares of the financial services provider's stock worth $57,000 after purchasing an additional 228 shares during the period. Finally, Captrust Financial Advisors boosted its stake in Trupanion by 45.2% during the 2nd quarter. Captrust Financial Advisors now owns 1,297 shares of the financial services provider's stock worth $78,000 after purchasing an additional 404 shares during the period. 97.85% of the stock is owned by hedge funds and other institutional investors.

About Trupanion

(Get Rating)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Featured Articles

• Get a free copy of the StockNews.com research report on Trupanion (TRUP)
• Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
• MarketBeat: Week in Review 9/19 – 9/23
• Why Does Tesla Stock Remain Resilient?
• 2 Semiconductor Stocks To Watch For Reversals
• Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.